| Literature DB >> 30257689 |
Benedikt Kleineidam1, Sonja Sielker2, Marcel Hanisch3, Johannes Kleinheinz3, Susanne Jung3.
Abstract
BACKGROUND: Adult stem cells appear to be a promising subject for tissue engineering, representing an individual material for regeneration of aged and damaged cells. Especially adipose derived stromal cells (ADSC), which are easily to achieve, allow an encouraging perspective due to their capability of differentiating into miscellaneous cell types. Here we describe the in vitro formation of human subcutaneous, visceral and omental ADSC micromasses and compare their histological attributes while being cultivated on collagen membranes.Entities:
Keywords: HADSC; Micromass; Multipotency; Regeneration
Mesh:
Year: 2018 PMID: 30257689 PMCID: PMC6158821 DOI: 10.1186/s13005-018-0178-0
Source DB: PubMed Journal: Head Face Med ISSN: 1746-160X Impact factor: 2.151
Fig. 1Cell tracking of subcutaneous fat tissue derived cells during micromass formation using the software Micro Trac (software: PD Dirksen, Uni Muenster; blue arrows = distance covered; red arrows = current movement)
Fig. 2Micromass formation process of subcutaneous fat tissue derived cells (scale bar = 500 μm)
Fig. 3Micromass formation process of visceral fat tissue derived cells (scale bar = 500 μm)
Fig. 4Micromass formation process of omental fat tissue derived cells (scale bar = 500 μm)
Fig. 5Mean velocity a) and distance to centre of gravity b) of subcutaneous, visceral and omental fat tissue derived cells during micromass formation process
Fig. 6HE Staining of subcutaneous, visceral and omental fat tissue derived micromasses after 1 week of culturing. Subcutaneous micromasses are more homogeneous and compact as compared to visceral and omental ones
Fig. 7HE-Staining of cultivated subcutaneous, visceral and omental fat tissue derived cell-micromasses on collagen membranes
Semi quantitative IHC score of stem cell markers in hADSC on collagen scaffolds (standard deviation in brackets)
| hADSC from subcutaneous fat | hADSC from visceral fat | hADSC from omental fat | ||||
|---|---|---|---|---|---|---|
| CD44 | ||||||
| Day 1 | 2.2 | (±0.1) | 3 | (±0) | 1.3 | (±0.4) |
| Day 7 | 2.7 | (±0.4) | 2.5 | (±0) | 0.8 | (±0.2) |
| Day 14 | 1.7 | (±0.4) | 2 | (±0.2) | 0.8 | (±0.2) |
| Day 28 | 0 | (±0) | 1 | (±0) | 0 | (±0) |
| CD90 | ||||||
| Day 1 | 1 | (±0.6) | 1.3 | (±0.2) | 3 | (±0) |
| Day 7 | 2.2 | (±0.6) | 2.4 | (±0.4) | 2.3 | (±0.3) |
| Day 14 | 1.3 | (±0.4) | 1.7 | (±0.1) | 2.5 | (±0) |
| Day 28 | 0.7 | (±0.4) | 1.3 | (±0.2) | 1 | (±0.4) |
| CD13 | ||||||
| Day 1 | 2.3 | (±0.4) | 0.8 | (±0.2) | 1 | (±0) |
| Day 7 | 1. 7 | (±0.4) | 1.4 | (±0.3) | 1 | (±0) |
| Day 14 | 2.3 | (±0.4) | 1 | (±0.1) | 1 | (±0) |
| Day 28 | 2.3 | (±0.4) | 0.8 | (±0.6) | 0.8 | (±0.2) |